Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Randomized Controlled Non-inferiority Trial Comparing Ketamine With ECT in Patients With Major Depressive Disorder

To see complete record on, please visit this link

Id: NCT02659085

Organisation Name: Region Skane

Overal Status: Completed

Start Date: February 2015

Last Update: December 19, 2019

Lead Sponsor: Pouya Movahed Rad

Brief Summary: Developing more effective and faster acting antidepressant is of outmost clinical importance. Available antidepressant therapies have a delayed therapeutic effect. It typically takes several weeks before symptom relief is evident. Furthermore, antidepressants are relatively ineffective - as many as 30% of patients do not respond to any medication at all. In this study the investigators evaluate the NMDA-receptor antagonist ketamine as a potentially new antidepressant treatment for severely depressed patients and compare its effectiveness with that of electroconvulsive therapy (ECT).

  • Depressive Disorder, Major

Total execution time in seconds: 0.31395196914673